Development of Curative Therapies for Ewing Sarcomas by Interdisciplinary Cooperative Groups in Europe

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10295004" target="_blank" >RIV/00216208:11130/15:10295004 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/15:10295004

Výsledek na webu

<a href="http://dx.doi.org/10.1055/s-0035-1545263" target="_blank" >http://dx.doi.org/10.1055/s-0035-1545263</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1055/s-0035-1545263" target="_blank" >10.1055/s-0035-1545263</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Development of Curative Therapies for Ewing Sarcomas by Interdisciplinary Cooperative Groups in Europe

Popis výsledku v původním jazyce

Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have ledto an increase of long-term disease-free survival to around 70 % in patients with localized disease. Translational research in ES remains an area in which interdisciplinary and international cooperation is essential for future progress. This article reviews current state-of-the art therapy, with a focus on trials performed in Europe, and summarizes novel strategies to further advance both the cure rates and quality of survival.

Název v anglickém jazyce

Development of Curative Therapies for Ewing Sarcomas by Interdisciplinary Cooperative Groups in Europe

Popis výsledku anglicky

Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have ledto an increase of long-term disease-free survival to around 70 % in patients with localized disease. Translational research in ES remains an area in which interdisciplinary and international cooperation is essential for future progress. This article reviews current state-of-the art therapy, with a focus on trials performed in Europe, and summarizes novel strategies to further advance both the cure rates and quality of survival.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Klinische Padiatrie

ISSN

0300-8630

e-ISSN

—

Svazek periodika

227

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

8

Strana od-do

108-115

Kód UT WoS článku

000354653100002

EID výsledku v databázi Scopus

2-s2.0-84929575169